REAGENTS AND METHODS FOR DETECTING PNH TYPE II WHITE BLOOD CELLS AND THEIR IDENTIFICATION AS RISK FACTORS FOR THROMBOTIC DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130045192A1
SERIAL NO

13508909

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure relates to methods for detecting PNH Type II cell populations in biological samples as well as methods for determining whether a patient is at an increased risk for developing thrombocytopenia or thrombosis based on the percentage of PNH Type II cells in the patient's blood. The disclosure also features reagents and conjugates for use in the methods.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALEXION PHARMACEUTICALS INC121 SEAPORT BOULEVARD BOSTON MA 02210

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Faas, McKnight Susan Old Lyme, US 11 109
Illingworth, Andrea Holden, US 4 8
Movalia, Mayur Brewer, US 4 8
Rother, Russell P Oklahoma City, US 62 897

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation